• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Are HIS vendors a threat to PACS firms?

Article

Are HIS vendors a threat to PACS firms?The PACS marketplace has traditionally been a radiology-centric business. Hospital information systems vendors have for the most part watched the PACS game from the sidelines, perhaps due to wariness about

Are HIS vendors a threat to PACS firms?

The PACS marketplace has traditionally been a radiology-centric business. Hospital information systems vendors have for the most part watched the PACS game from the sidelines, perhaps due to wariness about the large size of image data files, thorny communication service requirements, and their unfamiliarity with radiology departments. The technically demanding aspects of PACS have been best left to vendors accustomed to dealing with the needs of radiology, such as x-ray film or scanner modality vendors.

But HIS vendors are eyeing PACS as interest grows in the electronic medical record and integrated information and image management systems, and the need for these systems will only increase with the mushrooming of managed care and hospital networks. When HIS vendors begin offering PACS modules with their products, there is the definite possibility that hospitals may find this one-stop-shopping approach to information technology more attractive than being forced to buy separate IT components.

What role will PACS vendors play in this new environment? They will continue to thrive, because HIS vendors will still need the hard-earned years of expertise that PACS companies have acquired. Some PACS firms will likely partner with HIS vendors, while others will focus on radiology departments, which will remain a profitable business segment for the foreseeable future. Whatever the role, the demanding requirements of PACS ensure that vendors who have cut their teeth in this enigmatic market will not see their growing pains go for naught.

-Erik L. Ridley, Editor

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.